Themes

Mirum expands rare disease portfolio with digestive disorder drugs

Mirum Therapeutics acquired Travere’s Cholbam and Chenodal drugs that are approved to treat rare disorders.

Artificial Intelligence

View More

Cloud

View More

Corporate Governance

View More

Cybersecurity

View More

Environmental Sustainability

View More

Internet of Things

View More

Robotics

View More

Social Responsibility

View More

Covid-19

View More